UC Temuco
Temuco, Chile
NCT Number: NCT04390932
The therapeutic alliance (TA) is the working relationship or positive social bond between the patient and the therapist. TA is based on collaboration, communication, empathy of the therapist and mutual respect. Fostering an enhanced therapeutic alliance is a low-cost, therapist-dependent strategy that can accompany any clinical intervention. Growing evidence suggests that the TA plays a pivotal role in clinical outcomes in psychotherapy, medicine and physiotherapy interventions for chronic low back pain. On the other hand, therapeutic exercise is an economic, accessible and simple intervention strategy that has proven to be effective and safe to decrease pain and improve physical function in people with knee osteoarthritis (OA). To date, the role of TA in the management of knee OA is unknown. We hypothesized that a therapeutic exercise protocol accompanied by an enhanced TA could reduce the severity of symptoms and improve function in patients with symptomatic knee OA.
Looking for future studies?
Notify Me45 year–65 year
All sexes
Interventional
Not applicable
Temuco, Chile
The objective of this randomized clinical trial will be to determine the effects of different levels of TA during the application of a therapeutic exercise program on pain intensity, pressure pain thresholds and function in patients with symptomatic knee OA.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The enhanced TA is characterized by the personalization of the conversation, the verbalization of a joint participation in the process, the full presence of the therapist in the development of the exercise protocol, and the inclusion of behaviors such as active listening, empathy, and encouragement. In addition, therapist's body language transmits confidence, security, and attention.
The limited TA does not consider the personalization of the conversation, uses a unidirectional verbalization and is imperative about the instructions provided to the participant, the therapist is intermittently absent during the therapeutic exercise sessions and uses a neutral or negative nonverbal language cues.
Three 45-60 minute sessions of supervised therapeutic exercise (combination of aerobic, isometric, and isotonic exercise) delivered within a one-week period.
Time frame: 48 hours post intervention
Change in numerical pain rating scale (PI-NRS)
Time frame: 48 hours post intervention
Change in pressure algometry
Time frame: Only in the evaluation of the baseline.
WOMAC physical function section
Time frame: 48 hours post intervention
Work Alliance Sub-scale of the Rehabilitation Expectations Scale (PRES)
Time frame: Only in the evaluation of the baseline.
Credibility and Expectations Questionnaire
Time frame: Only in the evaluation of the baseline.
Change in pressure algometry after application of cold inmmersion test
Time frame: Only in the evaluation of the baseline.
Hospital Anxiety and Depression Scale (HADS)
Universidad Catolica de Temuco
Other
The Impact of Therapeutic Alliance on Clinical Outcomes in Patients With Symptomatic Knee Osteoarthritis. A Randomized Clinical Trial Protocol.
Acronym: ALLIANCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02905799
Arthritis, Joint Diseases
Paris, France
View Trial DetailsNCT07403383
Arthritis, Joint Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05618782
Arthritis, Connective Tissue Diseases
Brno, Czechia
View Trial DetailsNCT05543486
Arthritis, Joint Diseases
Calgary, Alberta, Canada
View Trial Details